This is the new favourite retail-exposed stock among brokers

JB Hi-Fi Limited (ASX: JBH) has long been the benchmark in the consumer sector but it's being replaced by Breville Group Ltd (ASX: BRG). Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There aren't many reasons to feel bullish about the retail sector as this reporting season has shown but there's one consumer-facing stock that's winning over sceptics.

I am referring to Breville Group Ltd (ASX: BRG) as it is fast becoming the favoured stock in the sector by brokers following its half year results last week.

The home appliances group has replaced electronics retailer JB Hi-Fi Limited (ASX: JBH) – a stock with a track record of defying the naysayers by delivering better-than-expected growth.

But brokers worry that conditions have peaked for JB Hi-Fi while Breville still has a number of growth levers to pull, such as its European expansion and the launch of a new range of coffee machines.

Ord Minnett upgraded the stock to "buy" from "hold" even though Breville's first half normalised net profit of $36.3 million was 2% below the broker's forecast.

But the broker was willing to overlook that as it was impressed with the company's strong 16% growth in constant currency terms.

While Ord Minnett believes growth will slow to 8% in the current half, it will surge ahead 14% in FY19 and 11% the year after thanks to Breville's new products and expansion into new markets.

"The most attractive feature of the growth, in our view, is that it is self-funded and global, and we believe Breville's brands are well positioned with 11% growth in FY18, even in somewhat of an 'investment' year," said Ord Minnett, which has a price target of $15.60 on the stock.

"Therefore, we are comfortable with Breville trading at a premium to the market."

Credit Suisse also upgraded the stock to "outperform" from "neutral" on the back of Breville's interim results.

The broker noted that sales growth is accelerating, its recent product launches are delivering pleasing results, its depressed earnings before interest and tax (EBIT) is due to a temporary increase in marketing and research and development costs, the additional investment is helping to build the brand internationally and there is an earnings tailwind in FY19 as Breville transitions to a direct delivery model (as opposed to using third parties) in Germany and Austria.

Perhaps Breville is trying to mimic online retail giant Amazon.com in doing direct. Amazon's arrival in Australia has triggered a shakeup in the retail sector. The troubles at Myer Holdings Ltd (ASX: MYR) is symptomatic of the structural change in the industry as the embattled department store is haunted by its "Christmas Past" in the form of Solomon Lew.

Mr Lew is the chairman of Premier Investments Limited (ASX: PMV), which is a major shareholder in Myer, and he is agitating for a board spill at Myer.

Thankfully, Breville is relatively insulated from the retail disruption as it's a manufacturer and distributor with a strong brand and successful international operations.

But it isn't all good news. Breville's first half cash flow was weak although a build-up in inventory of Nespresso products probably explains this.

If you are looking for other buying opportunities, particularly among potential "disruptors", the experts at the Motley Fool have some exciting news.

They have found three disruptors of tomorrow that they believe will outperform in 2018 and beyond. Click on the free link below to find out what these stocks are and why they should be on your radar.

Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Premier Investments Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »